Navigation Links
Cell Genesys to Present at the BIO Investor Forum
Date:10/3/2007

SOUTH SAN FRANCISCO, Calif., Oct. 3 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE), today announced that Robert Dow, MBChB, chief medical officer of Cell Genesys, will present a company update on Wednesday, October 10, at 10:15 a.m. PT at the BIO Investor Forum being held in San Francisco, California.

A live audio webcast of the presentation will be accessible through the Investor Relations section of the Cell Genesys website, http://www.cellgenesys.com. If you are unable to listen to the live webcast, it will be archived on the site for at least 72 hours following the presentation. To access the replay, go to the Investor Relations section of the website.

Cell Genesys is focused on the development and commercialization of novel biological therapies for patients with cancer. The company is currently pursuing two clinical stage product platforms -- GVAX(TM) cancer immunotherapies and oncolytic virus therapies. Ongoing clinical trials include Phase 3 trials of GVAX immunotherapy for prostate cancer, Phase 2 trials of GVAX immunotherapies for pancreatic cancer and for leukemia, and a Phase 1 trial of CG0070 oncolytic virus therapy for bladder cancer. Cell Genesys continues to hold an equity interest in its former subsidiary, Ceregene, Inc., which is developing gene therapies for neurodegenerative disorders. Cell Genesys is headquartered in South San Francisco, CA and has its principal manufacturing operation in Hayward, CA. For additional information, please visit the company's website at http://www.cellgenesys.com.

Contact:

Susan Ferris

Investor Relations

650-266
'/>"/>

SOURCE Cell Genesys, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...RNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. ...on the development of compounds for the treatment ...ounced that it has completed the last patient visi...1. ,, The FDG-PET trial enrolled 52 patients a...ada including Massachusetts General Hospital, Moun...
(Date:12/3/2009)...PRNewswire-FirstCall/ -- Inverness Medical Innovat...ling individuals to take charge of their health at...health management, has declared a dividend of $3.0...Preferred Stock ( IMA-PB). The dividend will be pa...are equal to the quotient of (a) $3.00 divided by ...
(Date:12/2/2009)...PRNewswire-FirstCall/ -- Martek Biosciences Corpor...ends to release the results of its fourth quarter ...oximately 4:00 p.m. Eastern Time (ET). Following ... conference call to discuss these results with inv...call live via webcast by visiting Martek,s web sit...
(Date:12/2/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Carbondioxide Incubators - A Global ....com/p0164368/Carbondioxide-Incubators---A-Global-... most critical equipment used in microbiology, gen...r providing a controlled environment to grow and s...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...orts the potential for QLT,s drug elution technolo...r pressure, VANCOUVER, May 12 /PRNewswire-FirstCa...today results from a proof of concept trial conduc...ivery, Inc., of its punctal plug,drug delivery tec...elution,technology was effective in controlling in...
... May 12 WaferGen Biosystems,Inc. (OTC Bulletin Bo...t,gene expression, genotyping, cell biology and st...Alnoor Shivji, President and Chief Executive,Offic...odman & Renshaw,Fifth Annual Global Healthcare Con...08, at the Le Meridien Beach Plaza Hotel in Monte ...
...f., May 9 Bionovo, Inc.,(Nasdaq: BNVI ) today an...uarter Results, The company did not report any re...evenues for the three months ended March 31, 2007 ...logy transfer agreement with United,Biotechnology ...inated the,agreement following notice of material ...
Other Biology Technology:QLT reports initial proof of concept data for punctal plug delivery technology 2QLT reports initial proof of concept data for punctal plug delivery technology 3QLT reports initial proof of concept data for punctal plug delivery technology 4WaferGen to Present at the Rodman and Renshaw Fifth Annual Global Healthcare Conference 2Bionovo Reports First Quarter 2008 Financial Results 2Bionovo Reports First Quarter 2008 Financial Results 3Bionovo Reports First Quarter 2008 Financial Results 4Bionovo Reports First Quarter 2008 Financial Results 5Bionovo Reports First Quarter 2008 Financial Results 6
(Date:12/2/2009)... PHILADELPHIA Cigarette smoking and alcohol consu...gly predicts the patient,s future risk of death, a...ew study show a similar effect among those who con...ost cancer survivors are counseled to quit smoking... percent continued to smoke even after their cance...
(Date:12/2/2009)..., PHILADELPHIA Exposure to secondhand smoke for ...y increase the risk of breast cancer, even in wome...e question of whether exposure to side-stream smok... is unresolved," said Peggy Reynolds, Ph.D., senio...ncer Center,s Berkeley office. "While no single ep...
(Date:12/2/2009)... Recalls of ground beef, peanut butter, and other ...nd concern about food safety. They also are quietl...uipment and fostering new food safety regulations....he current issue of Chemical & Engineering News ,...te Editor Jyllian Kemsley and Senior Correspondent...
Breaking Biology News(10 mins):Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Mediterranean Diet May Help Prevent Depression 58895 1Mediterranean Diet May Help Prevent Depression 58895 2Mediterranean Diet May Help Prevent Depression 58895 3SAGE launches Genes 26amp 3B Cancer 58891 1SAGE launches Genes 26amp 3B Cancer 58891 2Fewer U S Schools Selling Less Nutritious Food and Beverages 58888 1Fewer U S Schools Selling Less Nutritious Food and Beverages 58888 2
...motherapy drugs to specific cancer cells without t...ay be possible thanks to a nanoscale drug delivery...Department of Energy,s Ames Laboratory. , Using ti... carry drugs inside living cells, Ames Laboratory ...o control whether or not the particle delivers its...
...om the University of Alberta, the Yerkes National ...e Emory Transplant Center has successfully transpl...ls into monkeys, a procedure the researchers say r... critical supply problem in clinical islet cell tr..., along with recent work at the University of Minn...
...ound probes built by researchers at Duke,s Pratt S...s of dogs. The engineers said their demonstration ...r view during human endoscopic surgeries in which ...cisions. , If the probes prove beneficial in human...nd safer endoscopic surgeries, said the Duke engin...
Other Biology News:Cellular scale drug delivery from the inside out 2Cellular scale drug delivery from the inside out 3Diabetes researchers pioneer islet cell xenotransplantation in primate studies 23D ultrasound device poised to advance minimally invasive surgery 23D ultrasound device poised to advance minimally invasive surgery 3
Chicken Anti-Nucleobindin 1 (NUCB1) Antibody, Unconjugated from CHEMICON
Anti-Presenilin-1, N-terminus Polyclonal Antibody, Unconjugated from CHEMICON
Goat Anti-Syne-1 (N-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Human Kallikrein 1 Monoclonal Antibody, Unconjugated, Clone 323803 from R&D Systems
Biology Products: